elhamkhani
/
Test2
/
Login
Register
TriplyDB
Test2
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q27852097-2C65A5C9-0C24-4A70-9B8D-2E4B284D1DA2
Q27852097-2C65A5C9-0C24-4A70-9B8D-2E4B284D1DA2
BestRank
Statement
http://www.wikidata.org/entity/statement/Q27852097-2C65A5C9-0C24-4A70-9B8D-2E4B284D1DA2
Multicenter phase I trial of the mitogen-activated protein kinase 1/2 inhibitor BAY 86-9766 in patients with advanced cancer.
P921
Q27852097-2C65A5C9-0C24-4A70-9B8D-2E4B284D1DA2
BestRank
Statement
http://www.wikidata.org/entity/statement/Q27852097-2C65A5C9-0C24-4A70-9B8D-2E4B284D1DA2
rank
NormalRank
type
BestRank
Statement
P921
phase I clinical trial